ArticleDisease models & mechanisms2026
Gut-derived Unpaired-3 cytokine signaling promotes systemic hypoxia tolerance in Drosophila.
Article in Disease models & mechanisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Systemic hypoxia - a reduction in oxygen supply to all tissues and organs - occurs in many physiological and pathological conditions, including fetal development, high-altitude exposure, and disorders such as sleep apnea and respiratory disease. Under these conditions, whole-body physiology must adapt to ensure proper tissue functioning and survival. Although extensive research has characterized how individual cells sense and adapt to low-oxygen conditions, the mechanisms that coordinate whole-body responses to systemic hypoxia remain poorly understood. In this study, we uncovered an inter-organ signaling response mediated by the cytokine Unpaired-3 (Upd3), a functional homolog of human interleukin-6 (IL-6), that is important for systemic hypoxia tolerance in Drosophila. We demonstrated that hypoxia rapidly induces Upd3 expression and activates JAK/STAT signaling in larvae and adults. Interestingly, we discovered a sex-specific requirement for this pathway, with females, but not males, requiring Upd3 for hypoxia survival. We also identified the intestine as a critical source of hypoxia-induced Upd3 and showed that gut-derived Upd3 signals to the fat body and oenocytes to mediate hypoxia tolerance by promoting expression of nitric oxide synthase, the FGF ligand Branchless and the kinase Hipk. Furthermore, we revealed an unexpected role for the canonical hypoxia response transcription factor HIF-1α/Sima as a molecular brake, which prevents lethal Upd3 overproduction, revealing that hypoxia survival requires precise cytokine dosage control. Our findings define a gut-to-fat body signaling axis that coordinates systemic hypoxia adaptation, highlighting cytokine-mediated inter-organ communication as a mechanism for whole-body adaptation to low oxygen, with potential relevance to hypoxia-related human pathologies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.